Delivery Order SPE2DB20D1004-SPE2DB24FF0K9
- Not listed
- This federal contract award, valued at $7,507.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 1,200,000 units of Bicillin L-A, a prescription medication, with an ultimate completion date of October 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also a for-profit organization registered in the System for Award Management...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 1,200,000 units of Bicillin L-A, a 2ML injection medication. The Firm Fixed Price delivery order, valued at $3,397.78, has an ultimate completion date of January 3, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,260.47 firm-fixed-price delivery order is for the supply of 2,400,000 units of Bicillin L-A, a prescription medication. The contract has an ultimate completion date of September 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,072.54 firm fixed-price delivery order is for the supply of 1,200,000 units of Bicillin L-A, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of July 6, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award, valued at $1,123.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a 2ML medication, with a completion date of July 11, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management (SAM.gov). This contract is not...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,072.54 firm fixed-price delivery order is for the supply of 1,200,000 units of Bicillin L-A, a penicillin-based medication, to support U.S. government medical requirements. The contract has an ultimate completion date of May 3, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 1,200,000 units of Bicillin L-A, a prescription medication. The $58,762.50 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) on April 15, 2024, with an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen....
- This federal contract award, valued at $1,118.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a medication, with an ultimate completion date of April 28, 2023. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of Bicillin L-A, a 1,200,000 unit, 2ml medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for $1,175.24. The contract has an ultimate completion date of January 26, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,175.24, is for the delivery of 1,200,000 units of Bicillin L-A, a medication used for the treatment of certain bacterial infections. The contract has a firm fixed price and an ultimate completion date of September 10, 2024. This award is not associated with a set-aside program, indicating open...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FF0K9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,083.61 firm fixed-price delivery order covers the supply of 1,200,000 units of Bicillin L-A, a prescription medication, with a completion date of December 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and is registered in the System for Award Management (SAM.gov) as a for-profit organization. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's extensive capabilities in meeting the diverse pharmaceutical and medical supply needs of multiple government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/13/23 |